未登录

F

Feng Zhou

Collaborative Innovation Center for Cancer Medicine

H指数:11

被引数:649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A nuclear-targeted PROTAC enables subcellular-selective degradation of AURKA

一种靶向细胞核的PROTAC实现了AURKA的亚细胞器选择性降解

Biochemical and Biophysical Research Communications

IF2.2

2026-08-180

PRE

Design, synthesis and biological activity of 8-hydroxy modified urolithin A derivatives as phosphodiesterase type II (PDE2) inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2025-04-010

PRE

Structure-based optimization of Toddacoumalone as highly potent and selective PDE4 inhibitors with anti-inflammatory effects

BIOCHEMICAL PHARMACOLOGY

IF5.6

2022-08-015

PRE

Construction of α,β-Diamino Diacid Derivatives with Adjacent Acyclic Tetrasubstituted Stereocenters

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2022-06-175

PRE

Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-02-2121

PRE

Organocatalytic Asymmetric Synthesis of Benzothiazolopyrimidines via [4+2] Cyclization of 2-Benzothiazolimines and Aldehydes

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2021-01-0620

PRE

Asymmetric Synthesis of Oxindole-Derived Vicinal Tetrasubstituted Acyclic Amino Acid Derivatives by the Mannich-Type Reaction

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2020-06-3014

PRE

Constructions of a Set of New Lanthanide-Based Coordination Polymers with Hatza Ligands (Hatza=5-Aminotetrazole-1-Acetic Acid)

CRYSTAL GROWTH & DESIGN

IF3.4

2009-10-0750

PREAI

Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino [6,7-f][1,10]phenanthrolin-13(12H)-one

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2008-05-0187

PREAI

DNA interactions of a functionalized ruthenium(II) mixed-polypyridyl complex [Ru(bpy)2ppd]2+

功能化钌 (II) 混合多吡啶配合物 [Ru(bpy)2ppd]2的DNA相互作用

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2006-09-01264

PREAI